Crisafulli S, Luxi N, Sultana J et al (2021) Global epidemiology of acromegaly: a systematic review and meta-analysis. Eur J Endocrinol 185:251–263. https://doi.org/10.1530/EJE-21-0216
Giustina A, Barkhoudarian G, Beckers A et al (2020) Multidisciplinary management of acromegaly: a consensus. Rev Endocr Metab Disord 21:667–678. https://doi.org/10.1007/s11154-020-09588-z
Mathieu D, Kotecha R, Sahgal A et al (2022) Stereotactic radiosurgery for secretory pituitary adenomas: systematic review and International Stereotactic Radiosurgery Society practice recommendations. J Neurosurg 136:801–812. https://doi.org/10.3171/2021.2.JNS204440
Sheehan J, Lee C-C, Bodach ME et al (2016) Congress of neurological surgeons systematic review and evidence-based guideline for the management of patients with residual or recurrent nonfunctioning pituitary adenomas. Neurosurgery 79:E539-540. https://doi.org/10.1227/NEU.0000000000001385
Singh R, Didwania P, Lehrer EJ et al (2020) Stereotactic radiosurgery for acromegaly: an international systematic review and meta-analysis of clinical outcomes. J Neurooncol 148:401–418. https://doi.org/10.1007/s11060-020-03552-2
Ding D, Mehta GU, Patibandla MR et al (2019) Stereotactic radiosurgery for acromegaly: an international multicenter retrospective cohort study. Neurosurgery 84:717–725. https://doi.org/10.1093/neuros/nyy178
Lee C-C, Vance ML, Xu Z et al (2014) Stereotactic radiosurgery for acromegaly. J Clin Endocrinol Metab 99:1273–1281. https://doi.org/10.1210/jc.2013-3743
Liu X, Kano H, Kondziolka D et al (2012) Gamma knife radiosurgery for clinically persistent acromegaly. J Neurooncol 109:71–79. https://doi.org/10.1007/s11060-012-0862-z
Pai F-Y, Chen C-J, Wang W-H et al (2019) Low-dose gamma knife radiosurgery for acromegaly. Neurosurgery 85:E20–E30. https://doi.org/10.1093/neuros/nyy410
Wu Y, Wang M, Xu Y et al (2021) Comparing primary gamma knife radiosurgery and postoperative gamma knife radiosurgery for acromegaly: a monocenter retrospective study. Clin Neurol Neurosurg 200:106385. https://doi.org/10.1016/j.clineuro.2020.106385
Graffeo CS, Perry A, Link MJ et al (2021) Biological effective dose as a predictor of hypopituitarism after single-fraction pituitary adenoma radiosurgery: dosimetric analysis and cohort study of patients treated using contemporary techniques. Neurosurgery 88:E330–E335. https://doi.org/10.1093/neuros/nyaa555
Huo M, Rose M, van Prooijen M et al (2022) Importance of Cobalt-60 dose rate and biologically effective dose on local control for intracranial Meningiomas treated with stereotactic radiosurgery. Neurosurgery 90:140–147. https://doi.org/10.1227/NEU.0000000000001755
Tuleasca C, Peciu-Florianu I, Leroy H-A et al (2020) Biologically effective dose and prediction of obliteration of unruptured arteriovenous malformations treated by upfront gamma knife radiosurgery: a series of 149 consecutive cases. J Neurosurg. https://doi.org/10.3171/2020.4.JNS201250
Balossier A, Tuleasca C, Cortet-Rudelli C et al (2021) Gamma knife radiosurgery for acromegaly: evaluating the role of the biological effective dose associated with endocrine remission in a series of 42 consecutive cases. Clin Endocrinol (Oxford) 94:424–433. https://doi.org/10.1111/cen.14346
Graffeo CS, Donegan D, Erickson D et al (2020) The impact of insulin-like growth factor index and biologically effective dose on outcomes after stereotactic radiosurgery for acromegaly: cohort study. Neurosurgery 87:538–546. https://doi.org/10.1093/neuros/nyaa054
Sheehan JP, Pouratian N, Steiner L et al (2011) Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg 114:303–309. https://doi.org/10.3171/2010.5.JNS091635
Melmed S, Bronstein MD, Chanson P et al (2018) A consensus statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14:552–561. https://doi.org/10.1038/s41574-018-0058-5
Magalhães J, Ventura N, Lamback EB et al (2022) A prospective study on the efficacy of oral estrogen in female patients with acromegaly. Pituitary 25:433–443. https://doi.org/10.1007/s11102-021-01204-w
Schilbach K, Gar C, Lechner A et al (2019) Determinants of the growth hormone nadir during oral glucose tolerance test in adults. Eur J Endocrinol 181:55–67. https://doi.org/10.1530/EJE-19-0139
Imber BS, Lin AL, Zhang Z et al (2019) Comparison of radiographic approaches to assess treatment response in pituitary adenomas: is recist or rano good enough? J Endocr Soc 3:1693–1706. https://doi.org/10.1210/js.2019-00130
Jones B, Hopewell JW (2019) Modelling the influence of treatment time on the biological effectiveness of single radiosurgery treatments: derivation of “protective” dose modification factors. Br J Radiol 92:20180111. https://doi.org/10.1259/bjr.20180111
R Core Team (2020) R: A language and environement for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/
Pollock BE, Jacob JT, Brown PD, Nippoldt TB (2007) Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission. J Neurosurg 106:833–838. https://doi.org/10.3171/jns.2007.106.5.833
Gutt B, Wowra B, Alexandrov R et al (2005) Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly. Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc 113:219–224. https://doi.org/10.1055/s-2005-837552
Kong D-S, Kim Y-H, Kim YH et al (2019) Long-term efficacy and tolerability of gamma knife radiosurgery for growth hormone-secreting adenoma: a retrospective multicenter study (MERGE-001). World Neurosurg 122:e1291–e1299. https://doi.org/10.1016/j.wneu.2018.11.038
Losa M, Gioia L, Picozzi P et al (2008) The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma. J Clin Endocrinol Metab 93:2546–2552. https://doi.org/10.1210/jc.2008-0135
Hopewell JW, Millar WT, Lindquist C et al (2013) Application of the concept of biologically effective dose (BED) to patients with vestibular Schwannomas treated by radiosurgery. J Radiosurgery SBRT 2:257–271
Jones B, Klinge T, Hopewell JW (2020) The influence of the α/β ratio on treatment time iso-effect relationships in the central nervous system. Int J Radiat Biol 96:903–909. https://doi.org/10.1080/09553002.2020.1748736
Pop LA, Millar WT, van der Plas M, van der Kogel AJ (2000) Radiation tolerance of rat spinal cord to pulsed dose rate (PDR-) brachytherapy: the impact of differences in temporal dose distribution. Radiother Oncol J Eur Soc Ther Radiol Oncol 55:301–315. https://doi.org/10.1016/s0167-8140(00)00205-x
留言 (0)